Fundraising Fox

Plexium

San Diego, US · Founded 2018 · 33 employees on LinkedIn · 8 known investors

Find your way into Plexium

Plexium is a targeted protein degradation company developing small molecule therapeutics for treating diseases with high unmet medical needs using their proprietary DELTA Discovery platform.

Founders & leadership

MM
Michael Martin, Ph.D.Chief Executive Officer, President
JFJorge F. DiMartino
Jorge F. DiMartinoinJorge F. DiMartino is a physician scientist with over 18 years of experience in oncology drug development, including strategic involvement in the early development of marketed cancer therapeutics such as vismodegib, venetoclax, and enasidenib. He is founder of Plexium, which develops targeted protein degradation therapies.
MMMichael Martin
Michael MartininPresident, Chief Executive OfficerInvestor at Takeda Ventures
SMStephen Mullennix
Stephen MullennixinChief Financial OfficerHe previously served as Chief Financial Officer and Chief Operating Officer at public and private companies in life sciences, biotechnology, and infrastructure, with experience leading public financings, M&A, and international teams.

Board

SMSerge Messerlian
Serge MesserlianinChief Executive OfficerOperating Partner, DCVC Bio at DCVC Bio
CC
Cariad ChesterinBoard director
PRPatrick Rivers
Patrick RiversinBoard directorPortfolio Manager at aMoon
LCLeon Chen
Leon CheninBoard directorPartner at The Column Group
RHRob Hopfner
Rob HopfnerinBoardManaging Director at Pivotal Life Sciences
GHGorjan Hrustanovic
Gorjan HrustanovicinBoard Member
MGMike Grey
Mike GreyinExecutive Chairman

Investors · 8

Reported raises · per SEC filings

Form D private placements

$60.1M disclosed across 1 round · 2025

$60.1MraisedAug 2025 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Serge MesserlianDirector
  • Cariad ChesterDirector
  • Patrick RiversDirector
  • Leon ChenDirector
  • Rob HopfnerDirector
  • Michael MartinExecutive Officer, Director
  • Michael GreyDirector
  • Stephen MullennixExecutive Officer
  • Gorjan HrustanovicDirector
Offering amount
$60.1M
Amount sold
$60.1M
First sale
Jul 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Plexium went on to found or lead other companies.

Competitors · 1

by search overlap

Companies competing with Plexium for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Plexium do?
Plexium is a targeted protein degradation company developing small molecule therapeutics for treating diseases with high unmet medical needs using their proprietary DELTA Discovery platform.
Who are Plexium's investors?
Plexium's investors include CRV (Charles River Ventures), DCVC (Data Collective), M Ventures, Neotribe Ventures, SoftBank Vision Fund, TCG Crossover, The Column Group, Pivotal Life Sciences.
How much funding has Plexium raised?
Plexium has disclosed $60.1M raised across 1 round.
Where is Plexium headquartered?
Plexium is headquartered in San Diego, US.